WayPoint Biomedical Company Top Insiders
| WYPH Stock | USD 0.0003 0.00 0.00% |
WayPoint Biomedical employs about 2 people. The company is managed by 2 executives with a total tenure of roughly 5 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Assessment of WayPoint Biomedical's management performance can provide insight into the firm performance.
| Steven Fox Insider Chief Officer |
| Phill Richer Insider Director Marketing |
WayPoint |
WayPoint Biomedical Management Team Effectiveness
WayPoint Biomedical's management efficiency ratios could be used to measure how well WayPoint Biomedical manages its routine affairs as well as how well it operates its assets and liabilities.WayPoint Biomedical Workforce Comparison
WayPoint Biomedical Holdings is rated below average in number of employees category among its peers. The total workforce of Shell Companies industry is at this time estimated at about 281. WayPoint Biomedical maintains roughly 2.0 in number of employees contributing less than 1% to equities listed under Shell Companies industry.
WayPoint Biomedical Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. WayPoint Biomedical Price Series Summation is a cross summation of WayPoint Biomedical price series and its benchmark/peer.
WayPoint Biomedical Notable Stakeholders
A WayPoint Biomedical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as WayPoint Biomedical often face trade-offs trying to please all of them. WayPoint Biomedical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting WayPoint Biomedical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Steven Fox | Chief Officer | Profile | |
| Phill Richer | Director Marketing | Profile |
About WayPoint Biomedical Management Performance
The success or failure of an entity such as WayPoint Biomedical often depends on how effective the management is. WayPoint Biomedical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of WayPoint management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the WayPoint management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment. WayPoint Biomedical Holdings was founded in 2004 and is based in Huntington Beach, California. Waypoint Biomed operates under Shell Companies classification in the United States and is traded on OTC Exchange.
WayPoint Biomedical Workforce Analysis
Traditionally, organizations such as WayPoint Biomedical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare WayPoint Biomedical within its industry.WayPoint Biomedical Manpower Efficiency
Return on WayPoint Biomedical Manpower
| Revenue Per Employee | 14.9K | |
| Revenue Per Executive | 14.9K | |
| Net Loss Per Employee | 272.1K | |
| Net Loss Per Executive | 272.1K |
Complementary Tools for WayPoint Pink Sheet analysis
When running WayPoint Biomedical's price analysis, check to measure WayPoint Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy WayPoint Biomedical is operating at the current time. Most of WayPoint Biomedical's value examination focuses on studying past and present price action to predict the probability of WayPoint Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move WayPoint Biomedical's price. Additionally, you may evaluate how the addition of WayPoint Biomedical to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |